close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sunflower Therapeutics

News headline image
Sunflower Therapeutics Receives Phase II NIH SBIR Funding to Pioneer Continuous Cell Disruption for Commercial Scale VLP Biomanufacturing
From Sunflower Therapeutics
Via Business Wire
News headline image
BioTesserae Conducts Milestone First in Dog Studies with Proprietary PD-1 Single Domain Antibody
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Completes Major Installation of Daisy Petal™ Systems at the Serum Institute of India, the World’s Largest Vaccine Manufacturer
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Receives First Milestone Payment Through Collaboration with SK bioscience on Cost-Effective HPV Vaccine
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Receives NIH SBIR Funding to Develop an Automated, Continuous Cell Disruption Platform for VLP-Based Vaccine Manufacturing
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Announces Exclusive Distribution Agreement with Alflow Scandinavia A/S
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Announces the First System Delivery and Installation of the Daisy Petal™ Perfusion Bioreactor System to BioBuilder
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Closes $3M Simple Agreement for Future Equity (SAFE) with Oversubscription
From Sunflower Therapeutics
Via Business Wire
News headline image
Sunflower Therapeutics Announces SK bioscience’s $2M SAFE Investment
From Sunflower Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.